StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd

<< Previous

Bullboard Posts

Next >>

Post by IainCaimbeulon Aug 22, 2024 2:56pm

126 Views

Post# 36192286

Call to Stagezero. Please hold for the next available agent.

And hold and hold and hold...

Seriously, I probably will not live long to get the next available agent.

Not answering their phones, not responding to emails, not putting out an update PR.

Looks like we are being ghosted. Oh, the pain of being jilted.

The MCTO was initiated 5 April 2024 - four months ago. There must be a statute of limitations on this chicanery.

Maybe one of our illustrious pumpers could intervene on our behalf with their old buddy Jimmy?

<< Previous

Bullboard Posts

Next >>

Advancing flagship Ishkõday Gold Project in Ontario